News related to Welchol (Colesevelam) and/or conditions it is approved for
Colesevelam HCl Lowered LDL Cholesterol In Pediatric Patients With Heterozygous Familial Hypercholesterolemia Source: Cardiovascular / Cardiology News From Medical News Today [2008.11.17] Daiichi Sankyo, Inc. (DSI), announced today that results from the pivotal study supporting the use of colesevelam HCl in pediatric patients with heterozygous familial hypercholesterolemia (heFH), were presented for the first time at the American Heart Association's (AHA) Annual Scientific Sessions 2008.